Yudelev M - Search Results

1

Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin's lymphoma cell lines.

Aref A, Mohammad R, Yudelev M, Choudhuri R, Strowbridge A, Orton C, al-Katib A. Aref A, et al. Among authors: yudelev m. Radiat Oncol Investig. 1999;7(3):158-62. doi: 10.1002/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B. Radiat Oncol Investig. 1999. PMID: 10406057

2

Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines.

Aref A, Yudelev M, Mohammad R, Choudhuri R, Orton C, Al-Katib A. Aref A, et al. Among authors: yudelev m. Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):999-1003. doi: 10.1016/s0360-3016(99)00258-8. Int J Radiat Oncol Biol Phys. 1999. PMID: 10571208

3

Hip stiffness following mixed conformal neutron and photon radiotherapy: a dose-volume relationship.

Chuba PJ, Sharma R, Yudelev M, Duclos M, Shamsa F, Giacalone S, Orton CG, Maughan RL, Forman JD. Chuba PJ, et al. Among authors: yudelev m. Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):693-9. doi: 10.1016/0360-3016(96)00136-8. Int J Radiat Oncol Biol Phys. 1996. PMID: 8690635

4

Design considerations for a computer controlled multileaf collimator for the Harper Hospital fast neutron therapy facility.

Maughan RL, Yudelev M, Aref A, Chuba PJ, Forman J, Blosser EJ, Horste T. Maughan RL, et al. Among authors: yudelev m. Med Phys. 2002 Apr;29(4):499-508. doi: 10.1118/1.1463061. Med Phys. 2002. PMID: 11991121

5

Intensity modulated neutron radiotherapy for the treatment of adenocarcinoma of the prostate.

Santanam L, He T, Yudelev M, Forman JD, Orton CG, Heuvel FV, Maughan RL, Burmeister J. Santanam L, et al. Among authors: yudelev m. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1546-56. doi: 10.1016/j.ijrobp.2007.04.040. Int J Radiat Oncol Biol Phys. 2007. PMID: 17674984

6

Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapy.

Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Che M, Abrams J, Wang Y, Layer A, Wright JL, Rubio J, Forman JD. Hillman GG, et al. Among authors: yudelev m. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1426-37. doi: 10.1016/s0360-3016(03)00438-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 12873689

7

Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.

Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Rubio J, Tekyi-Mensah S, Layer A, Che M, Forman JD. Hillman GG, et al. Among authors: yudelev m. Clin Cancer Res. 2001 Jan;7(1):136-44. Clin Cancer Res. 2001. PMID: 11205901

8

Genistein potentiates the radiation effect on prostate carcinoma cells.

Hillman GG, Forman JD, Kucuk O, Yudelev M, Maughan RL, Rubio J, Layer A, Tekyi-Mensah S, Abrams J, Sarkar FH. Hillman GG, et al. Among authors: yudelev m. Clin Cancer Res. 2001 Feb;7(2):382-90. Clin Cancer Res. 2001. PMID: 11234894

9

Characteristic 8 keV X rays possess radiobiological properties of higher-LET radiation.

Shridhar R, Estabrook W, Yudelev M, Rakowski J, Burmeister J, Wilson GD, Joiner MC. Shridhar R, et al. Among authors: yudelev m. Radiat Res. 2010 Mar;173(3):290-7. doi: 10.1667/RR1782.1. Radiat Res. 2010. PMID: 20199214

10

Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.

Hillman GG, Wang Y, Kucuk O, Che M, Doerge DR, Yudelev M, Joiner MC, Marples B, Forman JD, Sarkar FH. Hillman GG, et al. Among authors: yudelev m. Mol Cancer Ther. 2004 Oct;3(10):1271-9. Mol Cancer Ther. 2004. PMID: 15486194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters